NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

心臟幫浦設備的全球市場 (∼2026年):各產品 (輔助人工心臟 ((LVAD、RVAD、BiVAD、pVAD)、大主動脈內氣球幫浦 、TAH)、類型 (體外式、置入式)、治療方法 (BTT、BTC、DT)、地區

Heart Pump Device Market by Product (Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD), Intra-aortic Balloon Pumps, TAH), Type (Extracorporeal and Implantable Pumps), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1007675
出版日期 內容資訊 英文 174 Pages
訂單完成後即時交付
價格
心臟幫浦設備的全球市場 (∼2026年):各產品 (輔助人工心臟 ((LVAD、RVAD、BiVAD、pVAD)、大主動脈內氣球幫浦 、TAH)、類型 (體外式、置入式)、治療方法 (BTT、BTC、DT)、地區 Heart Pump Device Market by Product (Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD), Intra-aortic Balloon Pumps, TAH), Type (Extracorporeal and Implantable Pumps), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2026
出版日期: 2021年05月21日內容資訊: 英文 174 Pages
簡介

全球心臟幫浦設備的市場規模在預測期間內預計以21.6%的年複合成長率發展,從2021年的21億美元,成長到2026年55億美元的規模。

心臟衰竭治療的研究投資、資金、津貼增加,心血管疾病的盛行率上升,等待心臟移植的期間長,心臟幫浦設備的有利償付環境,肥胖增加等要素促進該市場的成長。還有有潛力產品平台,產品核可數增加,預計成為新興市場在預測期間內市場成長的機會。

本報告提供全球心臟幫浦設備的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律制度,技術、專利分析,市場規模的變化、預測,各產品、類型、治療方法、地區/主要國家的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 供應鏈分析
  • 價值鏈分析
  • 生態系統分析
  • 法規情形
  • 波特的五力分析
  • COVID-19:影響分析
  • 專利分析
  • 貿易分析
  • 技術分析
  • 平均銷售價格
  • YCC轉移

第6章 市場分析、預測:各產品

  • 輔助人工心臟 (VAD)
    • 左心VAD
    • 經皮VAD
    • 兩心VAD
    • 右心VAD
  • 主動脈內氣球幫浦
  • 全置換型人工心臟 (TAH)

第7章 市場分析、預測:各類型

  • 植入式
  • 體外式

第8章 市場分析、預測:各治療法

  • BTT (BRIDGE-TO-TRANSPLANT)
  • BTC (BRIDGE-TO-CANDIDACY)
  • DT (DESTINATION THERAPY)
  • 其他

第9章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第10章 競爭情形

  • 概要
  • 收益分析
  • 市場佔有率分析
  • 企業評估矩陣
  • 競爭領導製圖:中小企業
  • 競爭模式
  • 企業足跡

第11章 企業簡介

  • 主要企業
    • ABBOTT LABORATORIES
    • ABIOMED
    • MEDTRONIC
    • TELEFLEX INCORPORATED
    • SYNCARDIA SYSTEMS
    • FRESENIUS MEDICAL CARE AG & CO. KGAA
    • CARDIACASSIST, INC.
    • GETINGE
  • 其他企業
    • BERLIN HEART
    • JARVIK HEART, INC.
    • CARMAT
    • SENKO MEDICAL INSTRUMENT MFG. CO., LTD.
    • ANGIODROID
    • CARDIODYME
    • WORLD HEART CORPORATION

第12章 附錄

目錄
Product Code: MD 6265

The global heart pump device market is projected to USD 5.5 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 21.6% from 2021 to 2026. The growth of this market is driven owing to increasing investments, funds, and grants for research on heart failure treatment; rising prevalence of cardiovascular diseases; long waiting periods for heart transplants; favorable reimbursements for heart pump devices; and increasing obesity. Also, promising product pipeline, increasing number of product approvals and emerging markets are anticipated to offer an opportunity for the growth of the market during the forecast period.

"Ventricular assist devices are expected to hold the largest share of the heart pump device market, by product in 2021."

Based on products, the heart pump devices market is segmented into ventricular assist devices, intra- aortic balloon pumps, and total artificial hearts. Ventricular assist devices are the largest and fastest-growing segment in this market. Growth in this segment can primarily be attributed to technological advancements, the shortage of organ donors, and the increasing prevalence of heart failure globally.

"Implantable heart pump devices are expected to hold the largest share of the heart pump device market, by type in 2021."

Based on type, the market is segmented into implantable heart pump devices and extracorporeal heart pump devices. In 2020, implantable heart pump devices accounted for the largest share of this market, due to the introduction of innovative products by leading players and the rising need for an efficient solution to manage heart failure.

"Bridge-to-transplant is expected to hold the largest share of the heart pump device market, by therapy in 2021."

Based on therapy, the market is segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT), and other therapies. In 2020, the BTT segment accounted for the largest share of this market. Growing awareness about transplantation and the availability of VADs for BTT have propelled the growth of this segment.

"Europe commanded the largest share of the heart pump device market in 2021."

On the basis of region, the heart pump device market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2020, Europe commanded the largest share of the heart pump device market. The large share of this market segment can be attributed to the rising adoption of heart pump devices, the high prevalence of CVDs, the growing number of research activities to improve current technologies, and the limited availability of donor hearts for transplants.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (33%), Europe (24%), AsiaPacific (27%), and Rest of the World (16%)

Some of the major players operating in this market are Abbott Laboratories (US), Abiomed (US), Medtronic (Ireland), Teleflex Incorporated (US), and Fresenius Medical Care AG & Co. KGaA (Germany)

List of Companies Profiled in the Report

  • Abbott Laboratories (US)
  • Abiomed (US)
  • Medtronic (Ireland)
  • Teleflex Incorporated (US)
  • SynCardia Systems (US)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Getinge (Sweden)
  • CardiacAssist, Inc. (US)
  • Berlin Heart (Germany)
  • Jarvik Heart, Inc. (US)
  • CARMAT (France)
  • SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. (Japan)
  • Angiodroid (Italy)
  • CardioDyme (US)
  • World Heart Corporation (US).

Research Coverage

This report studies the heart pump device market based on product, type, therapy, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total heart pump device market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on heart pump device offered by the top 15 players in the heart pump device market. The report analyzes the heart pump device market product, type, therapy, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the heart pump device market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the heart pump device market

Frequently asked questions

  • What are the growth opportunities in the heart pump device market across major regions in the future?
  • Which product is expected to hold the largest share in the heart pump device market?
  • Which region is anticipated to witness considerable growth in the heart pump device market?
  • Which are the driving factors of the heart pump device market?
  • What is the impact of COVID-19 on the heart pump device market?

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 HEART PUMP DEVICES: MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 BOTTOM-UP APPROACH
    • FIGURE 6 APPROACH 3: PARENT MARKET ANALYSIS [ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET]
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 8 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 COVID-19 ECONOMIC ASSESSMENT
  • 2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 10 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

    • FIGURE 12 HEART PUMP DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
    • FIGURE 13 HEART PUMP DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
    • FIGURE 14 HEART PUMP DEVICES MARKET, BY THERAPY, 2021 VS. 2026 (USD BILLION)
    • FIGURE 15 HEART PUMP DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD BILLION)

4 PREMIUM INSIGHTS

  • 4.1 HEART PUMP DEVICES MARKET OVERVIEW
    • FIGURE 16 THE RISING INCIDENCE OF HEART FAILURE IS A MAJOR FACTOR DRIVING THE GROWTH OF THE HEART PUMP DEVICES MARKET
  • 4.2 EUROPE: HEART PUMP DEVICES MARKET SHARE, BY THERAPY (2020)
    • FIGURE 17 BTT THERAPY SEGMENT DOMINATED THE EUROPEAN MARKET IN 2020
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE HEART PUMP DEVICES MARKET
    • FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 HEART PUMP DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing investments, funds, and grants for research on heart failure treatment
      • 5.2.1.2 Rising prevalence of cardiovascular diseases
    • FIGURE 20 SHARE OF GLOBAL POPULATION AGED 65 AND ABOVE (2015-2019)
      • 5.2.1.3 Long waiting periods for heart transplant procedures
      • 5.2.1.4 Favorable reimbursements for heart pump devices
    • TABLE 1 CPT CODES FOR PROCEDURES RELATED TO VENTRICULAR ASSIST DEVICES AND TAH
    • TABLE 2 CPT CODES FOR PROCEDURES RELATED TO IABP
      • 5.2.1.5 Increasing prevalence of obesity
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Complications associated with LVAD implantations
      • 5.2.2.2 Lack of funding for destination therapy
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Promising product pipeline
    • TABLE 3 TOTAL ARTIFICIAL HEARTS IN PIPELINE
      • 5.2.3.2 Increasing number of product approvals
    • TABLE 4 RECENT APPROVALS IN THE HEART PUMP DEVICES MARKET, 2018-2020
      • 5.2.3.3 Emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Frequent product recalls
    • TABLE 5 KEY PRODUCT RECALLS IN THE HEART PUMP DEVICES MARKET
      • 5.2.4.2 Stringent regulatory requirements delaying the approval of cardiac devices
  • 5.3 SUPPLY CHAIN ANALYSIS
    • FIGURE 21 DIRECT DISTRIBUTION-THE PREFERRED STRATEGY OF PROMINENT COMPANIES
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 22 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 23 ECOSYSTEM ANALYSIS OF THE HEART PUMP DEVICES INDUSTRY
    • 5.5.1 ROLE IN THE ECOSYSTEM
  • 5.6 REGULATORY LANDSCAPE
    • TABLE 6 LIST OF REGULATORY AUTHORITIES
    • 5.6.1 EU REGULATIONS
    • 5.6.2 US REGULATIONS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT FROM NEW ENTRANTS
    • 5.7.2 BARGAINING POWER OF SUPPLIERS
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 INTENSITY OF COMPETITIVE RIVALRY
    • 5.7.5 THREAT FROM SUBSTITUTES
  • 5.8 COVID-19 IMPACT ANALYSIS FOR THE HEART PUMP DEVICES MARKET
    • FIGURE 24 PERCENTAGE OF MEDTRONIC'S CARDIAC AND VASCULAR GROUP NET SALES, BY DIVISION, FY 2019 VS. FY 2020
  • 5.9 PATENT ANALYSIS
    • 5.9.1 VENTRICULAR ASSIST DEVICES
    • 5.9.2 TOTAL ARTIFICIAL HEARTS
    • 5.9.3 INTRA-AORTIC BALLOON PUMPS
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA, BY COUNTRY, 2017-2019 (USD MILLION)
    • 5.10.2 EXPORT DATA, BY COUNTRY, 2017-2019 (USD MILLION)
    • 5.10.3 EXPORT DATA, BY COUNTRY, 2017-2019 (KILOGRAMS)
    • 5.10.4 IMPORT DATA, BY COUNTRY, 2017-2019 (KILOGRAMS)
  • 5.11 TECHNOLOGY ANALYSIS
  • 5.12 AVERAGE SELLING PRICE TREND
    • TABLE 7 AVERAGE SELLING PRICES OF HEART PUMP DEVICE PRODUCTS
  • 5.13 YCC SHIFT

6 HEART PUMP DEVICES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 8 HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
  • 6.2 VENTRICULAR ASSIST DEVICES
    • TABLE 9 VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 10 VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.1 LEFT VENTRICULAR ASSIST DEVICES
      • 6.2.1.1 LVADs are the most common types of VAD used-a key factor driving market growth
    • TABLE 11 LEFT VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.2 PERCUTANEOUS VENTRICULAR ASSIST DEVICES
      • 6.2.2.1 Ability to provide efficient cardiac support to drive the growth of this market segment
    • TABLE 12 PERCUTANEOUS VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.3 BIVENTRICULAR ASSIST DEVICES
      • 6.2.3.1 Lack of reimbursement for BiVAD to restrict market growth to a certain extent
    • TABLE 13 BIVENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.4 RIGHT VENTRICULAR ASSIST DEVICES
      • 6.2.4.1 RVADs are used as temporary cardiac assist devices
    • TABLE 14 RIGHT VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 INTRA-AORTIC BALLOON PUMPS
    • 6.3.1 INCREASING RECALLS OF IABPS TO HINDER THE MARKET GROWTH
    • TABLE 15 RECENT IABP RECALLS IN THE HEART PUMP DEVICES MARKET
    • TABLE 16 INTRA-AORTIC BALLOON PUMPS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.4 TOTAL ARTIFICIAL HEARTS
    • 6.4.1 LAUNCH OF INNOVATIVE PRODUCTS TO ACCELERATE GROWTH IN THIS PRODUCT SEGMENT
    • TABLE 17 TOTAL ARTIFICIAL HEARTS MARKET, BY REGION, 2019-2026 (USD MILLION)

7 HEART PUMP DEVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 18 HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 7.2 IMPLANTABLE HEART PUMP DEVICES
    • 7.2.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GROWTH IN THIS MARKET SEGMENT
    • TABLE 19 IMPLANTABLE HEART PUMP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 EXTRACORPOREAL HEART PUMP DEVICES
    • 7.3.1 EXTRACORPOREAL HEART PUMP DEVICES CAN BE USED IN PEDIATRIC PATIENTS-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 20 EXTRACORPOREAL HEART PUMP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)

8 HEART PUMP DEVICES MARKET, BY THERAPY

  • 8.1 INTRODUCTION
    • TABLE 21 HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
  • 8.2 BRIDGE-TO-TRANSPLANT (BTT)
    • 8.2.1 GROWING NUMBER OF PATIENTS ON THE WAITING LIST TO SUPPORT MARKET GROWTH
    • TABLE 22 HEART PUMP DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT THERAPY, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 BRIDGE-TO-CANDIDACY (BTC)
    • 8.3.1 EFFICIENT OUTCOMES PROVIDED BY BTC TO PROPEL MARKET GROWTH
    • TABLE 23 HEART PUMP DEVICES MARKET FOR BRIDGE-TO-CANDIDACY THERAPY, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 DESTINATION THERAPY (DT)
    • 8.4.1 INTRODUCTION OF INNOVATIVE TECHNOLOGIES TO ACCELERATE SEGMENTAL GROWTH
    • TABLE 24 HEART PUMP DEVICES MARKET FOR DESTINATION THERAPY, BY REGION, 2019-2026 (USD MILLION)
  • 8.5 OTHER THERAPIES
    • TABLE 25 HEART PUMP DEVICES MARKET FOR OTHER THERAPIES, BY REGION, 2019-2026 (USD MILLION)

9 HEART PUMP DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 26 HEART PUMP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • TABLE 27 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 28 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 29 NORTH AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 30 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 31 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Availability of reimbursements to support market growth
    • TABLE 32 CPT CODES FOR PROCEDURES RELATED TO VAD AND TAH
    • TABLE 33 US: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 34 US: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 35 US: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 36 US: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Rising incidence and prevalence of heart failure to propel market growth
    • TABLE 37 CANADA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 38 CANADA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 39 CANADA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 40 CANADA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • FIGURE 25 EUROPE: HEART PUMP DEVICES MARKET SNAPSHOT
    • TABLE 41 EUROPE: HEART PUMP DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 42 EUROPE: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 43 EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 44 EUROPE: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 45 EUROPE: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 High adoption of VADs as destination therapy in Germany to drive market growth
    • TABLE 46 GERMANY: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 47 GERMANY: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 48 GERMANY: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 49 GERMANY: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Long waiting list for heart transplants in the UK
    • TABLE 50 UK: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 51 UK: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 52 UK: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 53 UK: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Developments undertaken by local players to accelerate market growth in France
    • TABLE 54 FRANCE: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 55 FRANCE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 56 FRANCE: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 57 FRANCE: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Initiatives undertaken by local players to drive market growth in Italy
    • TABLE 58 ITALY: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 59 ITALY: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 60 ITALY: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 61 ITALY: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Rising geriatric population to propel market growth in Spain
    • TABLE 62 SPAIN: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 63 SPAIN: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 64 SPAIN: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 65 SPAIN: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 66 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050
    • TABLE 67 ROE: HEALTH EXPENDITURE (% OF GDP), 2010 VS. 2017
    • TABLE 68 ROE: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 69 ROE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 ROE: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 71 ROE: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 26 ASIA PACIFIC: HEART PUMP DEVICES MARKET SNAPSHOT
    • TABLE 72 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 73 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 74 ASIA PACIFIC: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Low rate of transplantations in the country to drive market growth
    • TABLE 77 JAPAN: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 78 JAPAN: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 79 JAPAN: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 80 JAPAN: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 High prevalence of CVDs in China to drive market growth
    • TABLE 81 CHINA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 82 CHINA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 83 CHINA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 CHINA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Huge target population in India to drive market growth
    • TABLE 85 INDIA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (US MILLION)
    • TABLE 86 INDIA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 87 INDIA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 INDIA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Increasing prevalence of heart disease to accelerate market growth in Australia
    • TABLE 89 AUSTRALIA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 90 AUSTRALIA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 AUSTRALIA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 AUSTRALIA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • TABLE 93 ROAPAC: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 94 ROAPAC: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 95 ROAPAC: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 ROAPAC: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • TABLE 97 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 98 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 99 REST OF THE WORLD: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 101 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.5.1 MIDDLE EAST & AFRICA
      • 9.5.1.1 Increasing adoption of heart pump devices in the region to drive market growth
    • TABLE 102 MIDDLE EAST & AFRICA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 103 MIDDLE EAST & AFRICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 MIDDLE EAST & AFRICA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 MIDDLE EAST & AFRICA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • 9.5.2 LATIN AMERICA
      • 9.5.2.1 Rising geriatric population to increase the demand for heart pump devices in the region
    • TABLE 106 LATIN AMERICA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 107 LATIN AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 108 LATIN AMERICA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 109 LATIN AMERICA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 27 KEY DEVELOPMENTS IN THE HEART PUMP DEVICES MARKET, JANUARY 2018-APRIL 2021
    • FIGURE 28 MARKET EVOLUTION MATRIX: JANUARY 2018 TO APRIL 2021
  • 10.2 REVENUE ANALYSIS
    • 10.2.1 HEART PUMP DEVICES MARKET: REVENUE ANALYSIS OF THE TOP 5 MARKET PLAYERS
    • FIGURE 29 TOP 5 PLAYERS HAVE DOMINATED THE MARKET IN THE LAST 3 YEARS
  • 10.3 MARKET SHARE ANALYSIS
    • TABLE 110 HEART PUMP DEVICES MARKET: DEGREE OF COMPETITION
  • 10.4 COMPANY EVALUATION MATRIX
    • 10.4.1 STARS
    • 10.4.2 EMERGING LEADERS
    • 10.4.3 PERVASIVE PLAYERS
    • 10.4.4 PARTICIPANTS
    • FIGURE 30 VENDOR DIVE: HEART PUMP DEVICES MARKET
  • 10.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 STARTING BLOCKS
    • 10.5.3 RESPONSIVE COMPANIES
    • 10.5.4 DYNAMIC COMPANIES
    • FIGURE 31 HEART PUMP DEVICES MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020
  • 10.6 COMPETITIVE SCENARIO
    • 10.6.1 PRODUCT APPROVALS
    • TABLE 111 KEY PRODUCT APPROVALS, JANUARY 2018-APRIL 2021
    • 10.6.2 DEALS
    • TABLE 112 KEY DEALS, JANUARY 2018-APRIL 2021
    • 10.6.3 OTHER DEVELOPMENTS
    • TABLE 113 OTHER KEY DEVELOPMENTS, JANUARY 2018-APRIL 2021
  • 10.7 COMPANY FOOTPRINT
    • TABLE 114 COMPANY FOOTPRINT
    • TABLE 115 COMPANY PRODUCT FOOTPRINT
    • TABLE 116 COMPANY TYPE FOOTPRINT
    • TABLE 117 COMPANY GEOGRAPHICAL FOOTPRINT

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)**
    • 11.1.1 ABBOTT LABORATORIES
    • TABLE 118 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
    • 11.1.2 ABIOMED
    • TABLE 119 ABIOMED: BUSINESS OVERVIEW
    • FIGURE 33 ABIOMED: COMPANY SNAPSHOT (2020)
    • 11.1.3 MEDTRONIC
    • TABLE 120 MEDTRONIC: BUSINESS OVERVIEW
    • FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT (2020)
    • 11.1.4 TELEFLEX INCORPORATED
    • TABLE 121 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 35 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020)
    • 11.1.5 SYNCARDIA SYSTEMS
    • TABLE 122 SYNCARDIA SYSTEMS: BUSINESS OVERVIEW
    • 11.1.6 FRESENIUS MEDICAL CARE AG & CO. KGAA
    • TABLE 123 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW
    • FIGURE 36 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2020)
    • 11.1.7 CARDIACASSIST, INC.
    • TABLE 124 CARDIACASSIST, INC.: BUSINESS OVERVIEW
    • FIGURE 37 LIVANOVA PLC: COMPANY SNAPSHOT (2020)
    • 11.1.8 GETINGE
    • TABLE 125 GETINGE: BUSINESS OVERVIEW
    • FIGURE 38 GETINGE: COMPANY SNAPSHOT (2020)
  • 11.2 OTHER PLAYERS
    • 11.2.1 BERLIN HEART
    • TABLE 126 BERLIN HEART: BUSINESS OVERVIEW
    • 11.2.2 JARVIK HEART, INC.
    • TABLE 127 JARVIK HEART, INC.: BUSINESS OVERVIEW
    • 11.2.3 CARMAT
    • TABLE 128 CARMAT: BUSINESS OVERVIEW
    • 11.2.4 SENKO MEDICAL INSTRUMENT MFG. CO., LTD.
    • TABLE 129 MERA: BUSINESS OVERVIEW
    • 11.2.5 ANGIODROID
    • TABLE 130 ANGIODROID: BUSINESS OVERVIEW
    • 11.2.6 CARDIODYME
    • TABLE 131 CARDIODYME: BUSINESS OVERVIEW
    • 11.2.7 WORLD HEART CORPORATION
    • TABLE 132 WORLD HEART CORPORATION: BUSINESS OVERVIEW
  • *Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS